From formulation to commercialization, Altasciences’ 64,000 square-foot, purpose-built FDA-inspected GMP facility features an analytical lab, a Research & Development formulations lab, and multiple manufacturing suites with cutting-edge Grade C cleanrooms, including segregated and dedicated potent handling areas. Our CDMO experts have over 100 years of combined experience in the management of pharmaceutical manufacturing and laboratory operations.
 
Our expertise includes: 

• Liquid and powder-filled capsules
• Nano-milled suspensions
• Creams
• Powders
• Terminally sterilized injectables

Catch a glimpse of the facility here.

Request a full virtual tour of our Philadelphia site today or contact us.
 
You may also be interested in the following:

• Webpage: Pharmaceutical Contract Manufacturing and Analytical Services
• The Altascientist: Maximizing Drug Formulation for First-in-Human Trials
• Webinar: Overcoming the Challenges of Manufacturing and Clinical Trials
• Podcast: Altasciences’ Manufacturing Solutions, Liquid-Filled Capsules

 
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Q&A with Catherine Dussault, Director of Scientific Affairs

Successful early phase drug development studies are grounded in a strong scientific rationale, and a deep understanding of regulatory requirements. Altasciences’ Scientific Affairs (SA) team combines these critical knowledge bases to support sponsors in designing and conducting the most appropriate studies for their unique development program.

Catherine Dussault,  Director, Scientific Affairs, Altasciences

Read the five things you need to know

Catherine Dussault is the Director of Altasciences’ Scientific Affairs team. She has been with Altasciences since 2004; and is a senior scientific leader with a deep knowledge of regulatory framework for various drug development clinical research programs. Catherine has overseen over 2,000 clinical trials, including Phase I and II, FIH, bioequivalence, 505(b)(2), drug-drug interactions, QTc, and proof of concept, in both healthy normal and special patient populations. She has extensive experience in multiple therapeutic areas, such as central nervous system, GI tract and metabolism, cardiovascular, genito-urinary system and sex hormones, antineoplastic and immunomodulating, and anti-infective agents.  

We are your one-stop solution for all your bioanalytical needs. We offer fully integrated bioanalytical laboratories that support our facilities and clinical sites. Most importantly, we ensure the success of your projects by anticipating challenges throughout the process with:

• A team of industry recognized, subject matter experts specialized in both small and large molecules
• 25+ years of regulatory experience
• Strategically located facilities situated in proximity to preclinical and clinical sites 
• A history of successful regulatory inspections
• Industry leading experience with GLP and GCP regulatory processes
• In-depth knowledge and experience with preclinical, first-in-human SAD/MAD, and Phase III bioanalytical study management and timelines

Partner with Altasciences today.

You may also be interested in the following:

• Factsheets:
  • Bioanalysis of Small Molecules Using Mass Spectrometry 
  • Bioanalysis Ligand Binding Assays
• Video: Bioanalysis Services
• Webinar: Transitioning Novel Scientific Workflows to Routine Bioanalysis

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

As your drug development partner, we have a deep appreciation of both the challenges and the potential of your small molecule. At Altasciences, we understand why developing your molecule requires tailored solutions at every stage. 

Find out how our small molecule solutions help identify new and improved approaches to study designs, and anticipate development challenges as studies evolve. 

Bring us your challenge. We have the solution.

Challenge us

You may also be interested in the following:

• Factsheet: Small Molecule Safety Assessment
• IND/CTA Guide: Planning your Preclinical Assessment
• Webpage: Bioanalytical Services

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Consultant Series ― Interview with Teresa Johnk 

Listen in as we discuss the role of a strategic business development consultant in drug development with industry veteran Teresa Johnk, Founder and CEO of BioPharma Connections.

In this podcast, we uncover:

• Important considerations to secure VC funding
• How to ensure the successful program completion
• What to look for in a consultant
• What to look for in a CRO/CDMO partner

Listen now

Connect with our industry experts.

You may also be interested in the following:

• Webinar: Overcoming the Challenges of Manufacturing and Clinical Trials
• Factsheet: Manufacturing and Analytical Services
• Webpage: Full-Time Equivalent (FTE) Capabilities

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

A Seamless Experience, Thanks to Expert Scientific Project Management

From lead candidate selection to clinical proof of concept, whether for a single study or multiple programs, Altasciences’ Scientific Project Management team manages every study with your business priorities in mind.

Join Lauren Szczurowski, Executive Director of Scientific Project Management, in this on-demand podcast as she reveals how Altasciences makes outsourcing early phase drug development a seamless experience.

Listen to Podcast

Schedule a conversation with one of our Scientific Project Managers to review your questions and requirements.

You may also be interested in the following:

• Video: The Benefits of Tell Us Once™
• Video: Your Road to Proactive Development with Altasciences
• Fact Sheet: First-in-Human Trial Capabilities
• Webpage: Full-Time Equivalent Capabilities